| Trial registration number
|
IRCT20220116053739N1 |
Full text link
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/61358
|
First author
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mehraban Sadeghi
|
Contact
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
vcrt@skums.ac.ir
|
Registration date
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2022-04-15
|
Recruitment status
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
The patient with IgM positive
The patient with confirmed molecular test
|
Exclusion criteria
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Having the background of Underlying disease
Any clinical or laboratory evidence of the patient need for Antibiotics
Lack of consent of the patient and his/her family for the participation in the study
|
Number of arms
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Shahre-kord University of Medical Sciences
|
Inclusion age min
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Inclusion age max
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
14
|
Countries
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Moderate disease at enrollment
|
Severity scale
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
3: Moderate disease at enrollment
|
Total sample size
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
70
|
primary outcome
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Duration of hospitalization
Complete blood count (CBC)
Fever
Cough
|
Notes
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : April 15, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 2436, "treatment_name": "Cefotaxime", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|